NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch. (2021)
Attributed to:
Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/antiox10091380
PubMed Identifier: 34573012
Publication URI: http://europepmc.org/abstract/MED/34573012
Type: Journal Article/Review
Volume: 10
Parent Publication: Antioxidants (Basel, Switzerland)
Issue: 9
ISSN: 2076-3921